Cargando…
HIV pre‐exposure prophylaxis for adolescent girls and young women in Africa: from efficacy trials to delivery
INTRODUCTION: Adolescent girls and young women (AGYW) in Africa have high HIV incidence despite scale‐up of HIV testing and HIV treatment. Placebo‐controlled trials of tenofovir‐based pre‐exposure prophylaxi (PrEP) in diverse populations demonstrated that PrEP works with close to 100% effectiveness...
Autores principales: | Celum, Connie L, Delany‐Moretlwe, Sinead, Baeten, Jared M, van der Straten, Ariane, Hosek, Sybil, Bukusi, Elizabeth A, McConnell, Margaret, Barnabas, Ruanne V, Bekker, Linda‐Gail |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6643076/ https://www.ncbi.nlm.nih.gov/pubmed/31328444 http://dx.doi.org/10.1002/jia2.25298 |
Ejemplares similares
-
Preventing HIV among adolescents with oral PrEP: observations and challenges in the United States and South Africa
por: Hosek, Sybil, et al.
Publicado: (2016) -
Assessing longitudinal patterns of depressive symptoms and the influence of symptom trajectories on HIV pre‐exposure prophylaxis adherence among adolescent girls in the HPTN 082 randomized controlled trial
por: Velloza, Jennifer, et al.
Publicado: (2021) -
Interventions to improve daily medication use among adolescents and young adults: what can we learn for youth pre-exposure prophylaxis services?
por: Velloza, Jennifer, et al.
Publicado: (2021) -
Family influences on oral PrEP use among adolescent girls and young women in Kenya and South Africa
por: Ndimande-Khoza, Makhosazane Nomhle, et al.
Publicado: (2023) -
Trust in the provider and accurate self-reported PrEP adherence among adolescent girls and young women in South Africa and Zimbabwe: HPTN 082 study
por: Beauchamp, Geetha, et al.
Publicado: (2023)